Your browser doesn't support javascript.
loading
Electrocardiogram abnormalities and prognosis in COVID-19.
Chevrot, Gabriel; Hauguel-Moreau, Marie; Pépin, Marion; Vieillard-Baron, Antoine; Lot, Anne-Sophie; Ouadahi, Mounir; Hergault, Hélène; Aïdan, Vincent; Greffe, Ségolène; Costantini, Adrien; Dubourg, Olivier; Beaune, Sébastien; Mansencal, Nicolas.
  • Chevrot G; Department of Cardiology, Ambroise Paré Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Centre de référence des cardiomyopathies et des troubles du rythme cardiaque héréditaires ou rares, Université de Versailles-Saint Quentin (UVSQ), Boulogne-Billancourt, France.
  • Hauguel-Moreau M; Department of Cardiology, Ambroise Paré Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Centre de référence des cardiomyopathies et des troubles du rythme cardiaque héréditaires ou rares, Université de Versailles-Saint Quentin (UVSQ), Boulogne-Billancourt, France.
  • Pépin M; INSERM U-1018, CESP, Epidémiologie clinique, UVSQ, Université de Paris Saclay, Villejuif, France.
  • Vieillard-Baron A; INSERM U-1018, CESP, Epidémiologie clinique, UVSQ, Université de Paris Saclay, Villejuif, France.
  • Lot AS; Department of Geriatrics, Ambroise Paré Hospital, AP-HP, UVSQ, Boulogne-Billancourt, France.
  • Ouadahi M; INSERM U-1018, CESP, Epidémiologie clinique, UVSQ, Université de Paris Saclay, Villejuif, France.
  • Hergault H; Intensive Care Unit, Ambroise Paré Hospital, AP-HP, UVSQ, Boulogne-Billancourt, France.
  • Aïdan V; FHU SEPSIS IFrancenserm UMR 1144, Université Paris Centre, Paris, France.
  • Greffe S; Department of Medical Information, Ambroise Paré Hospital, APHP, Boulogne-Billancourt, France.
  • Costantini A; Department of Cardiology, Ambroise Paré Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Centre de référence des cardiomyopathies et des troubles du rythme cardiaque héréditaires ou rares, Université de Versailles-Saint Quentin (UVSQ), Boulogne-Billancourt, France.
  • Dubourg O; Department of Cardiology, Ambroise Paré Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Centre de référence des cardiomyopathies et des troubles du rythme cardiaque héréditaires ou rares, Université de Versailles-Saint Quentin (UVSQ), Boulogne-Billancourt, France.
  • Beaune S; Department of Cardiology, Ambroise Paré Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Centre de référence des cardiomyopathies et des troubles du rythme cardiaque héréditaires ou rares, Université de Versailles-Saint Quentin (UVSQ), Boulogne-Billancourt, France.
  • Mansencal N; Department of Internal Medicine, Ambroise Paré University Hospital, AP-HP, UVSQ, Boulogne-Billancourt, France.
Front Cardiovasc Med ; 9: 993479, 2022.
Article en En | MEDLINE | ID: mdl-36277756
ABSTRACT

Background:

COVID-19 is a major pandemic with potential cardiovascular complications. Few studies have focused on electrocardiogram (ECG) modifications in COVID-19 patients. Method and

results:

We reviewed from our database all patients referred to our hospital for COVID-19 between January 1st, 2020, and December 31st, 2020 669 patients were included and 98 patients died from COVID-19 (14.6%). We systematically analyzed ECG at admission and during hospitalization if available. ECG was abnormal at admission in 478 patients (71.4%) and was more frequently abnormal in patients who did not survive (88.8 vs. 68.5%, p < 0.001). The most common ECG abnormalities associated with death were left anterior fascicular block (39.8 vs. 20.0% among alive patients, p < 0.001), left and right bundle branch blocks (p = 0.002 and p = 0.02, respectively), S1Q3 pattern (14.3 vs. 6.0%, p = 0.006). In multivariate analysis, at admission, the presence of left bundle branch block remained statistically related to death [OR = 3.82, 95% confidence interval (CI) 1.52-9.28, p < 0.01], as well as S1Q3 pattern (OR = 3.17, 95% CI 1.38-7.03, p < 0.01) and repolarization abnormalities (OR = 2.41, 95% CI 1.40-4.14, p < 0.01).On ECG performed during hospitalization, the occurrence of new repolarization abnormality was significantly related to death (OR = 2.72, 95% CI 1.14-6.54, p = 0.02), as well as a new S1Q3 pattern (OR = 13.23, 95% CI 1.49-286.56, p = 0.03) and new supraventricular arrhythmia (OR = 3.8, 95% CI 1.11-13.35, p = 0.03).

Conclusion:

The presence of abnormal ECG during COVID-19 is frequent. Physicians should be aware of the usefulness of ECG for risk stratification during COVID-19.
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Año: 2022 Tipo del documento: Article